Should You Invest In Regeneron Pharmaceuticals?

Get the facts about trading Regeneron Pharmaceuticals before you start. Discuss investment strategies, review market research, and get real-time updates

685,750 Regeneron Pharmaceuticals positions opened on eToro

REGNRegeneron Pharmaceuticals
577.81-8.44 ( -1.44%)
148.98 (0.29%)
2793.78 (1.33%)
372.52 (0.72%)
289.11 (-0.21%)
68.73 (-4.18%)

Regeneron Pharmaceuticals Inc. was founded in 1988 and is headquartered in Tarrytown, New York. It is a biopharmaceutical company focused on developing and commercializing medical solutions for eye diseases, high levels of cholesterol, asthma, atopic dermatitis, cancer, and other conditions. As of December 31, 2016, the Company has had six FDA-approved medicines, 16 product candidates in clinical development and 15 fully human monoclonal antibody product candidates. The company has collaboration and license agreements with Sanofi, Bayer, Teva and other companies. Learn more about this instrument and start trading.

Buy REGN Now
Sell REGN Now

Historical Price Charts

Discover the eToro Advantage

Use eToro's advanced risk management tools to protect your positions. Enjoy hassle-free deposits and withdrawals, instant execution of trades and a free $100,000 demo account to practice your strategy.

Volatility means opportunity! Watch price changes reflect directly onto your portfolio

Start trading within minutes - no physical purcase delays

Benefit from falling prices as well as rising prices. Buy or sell instantly


微信公众号: e投睿eToro

Start Trading
got it